98 results
Page 3 of 5
6-K
EX-99.2
mg9ip1qi000vj6
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.3
ocvrl1e8c9uyjtu
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.1
ov15jxa1ynujdu52wmvb
31 Mar 21
Current report (foreign)
7:15am
424B5
8bjl516 6tjcm
5 Mar 21
Prospectus supplement for primary offering
7:55am
6-K
EX-99.2
t511d0zi8waxcog6cj
17 Feb 21
ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference
6:04am
6-K/A
EX-99.1
ty4r3raksc rx8
19 Jan 21
Current report (foreign) (amended)
6:25am
6-K
EX-99.1
iypd4lhr82n
13 Jan 21
Current report (foreign)
4:00pm
6-K
EX-99.1
i6qixbywqs z4z5x
11 Jan 21
ObsEva Provides Update on Yselty® (Linzagolix) Clinical Development Program
7:05am
6-K
EX-99.2
mms0hqg39r
10 Dec 20
Current report (foreign)
6:03am
6-K
EX-99.1
5l2ylfczevp41 cjiff
24 Nov 20
Current report (foreign)
6:03am
6-K
EX-99.2
llto vx3kah8j5eo
16 Nov 20
ObsEva SA Reports Positive Topline Results of the PROLONG Proof-of-Concept Trial of Ebopiprant (OBE022) for Treatment of Preterm Labor
6:39am
424B5
duquu al8s
8 Sep 20
Prospectus supplement for primary offering
7:31am
6-K
EX-99.1
f7tt a0y2y4aj1mgo80
14 Aug 20
Current report (foreign)
4:24pm
6-K
EX-99.3
cwmrz3naxmhyc kuhw
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.2
wkit5xac tve5v66io
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.1
9ef8 fylfatr1c1lrl84
7 Jul 20
Current report (foreign)
3:39pm
6-K
EX-99.2
jeqbblr42b rk9vv8u
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am